A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer

NCT02344095 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Epithelial Ovarian Carcinoma
Fallopian Tube Carcinoma
Primary Peritoneal Carcinoma

Interventions

DRUG: weekly paclitaxel
DRUG: weekly cisplatin
DEVICE: oncothermia

Sponsor

Seoul National University Hospital